Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults
Importance
Traditional approaches to practice guidelines frequently result in dissociation between strength of recommendation and quality of evidence.
Objective
To create a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.
Evidence Review
This consensus statement and systematic review applied an approach previously established by the WikiGuidelines Group to construct collaborative clinical guidelines. In May 2023, new and existing members were solicited for questions on urinary tract infection prevention, diagnosis, and management. For each topic, literature searches were conducted up until early 2024 in any language. Evidence was reported according to the WikiGuidelines charter: clear recommendations were established only when reproducible, prospective, controlled studies provided hypothesis-confirming evidence. In the absence of such data, clinical reviews were developed discussing the available literature and associated risks and benefits of various approaches.
Findings
A total of 54 members representing 12 countries reviewed 914 articles and submitted information relevant to 5 sections: prophylaxis and prevention (7 questions), diagnosis and diagnostic stewardship (7 questions), empirical treatment (3 questions), definitive treatment and antimicrobial stewardship (10 questions), and special populations and genitourinary syndromes (10 questions). Of 37 unique questions, a clear recommendation could be provided for 6 questions. In 3 of the remaining questions, a clear recommendation could only be provided for certain aspects of the question. Clinical reviews were generated for the remaining questions and aspects of questions not meeting criteria for a clear recommendation.
Conclusions and Relevance
In this consensus statement that applied the WikiGuidelines method for clinical guideline development, the majority of topics relating to prevention, diagnosis, and treatment of urinary tract infections lack high-quality prospective data and clear recommendations could not be made. Randomized clinical trials are underway to address some of these gaps; however further research is of utmost importance to inform true evidence-based, rather than eminence-based practice.
Top-30
Journals
|
1
2
|
|
|
Open Forum Infectious Diseases
2 publications, 5.56%
|
|
|
JAMA network open
1 publication, 2.78%
|
|
|
Antibiotics
1 publication, 2.78%
|
|
|
CMI Communications
1 publication, 2.78%
|
|
|
Metabolites
1 publication, 2.78%
|
|
|
Journal of Infection and Public Health
1 publication, 2.78%
|
|
|
Acta Biochimica Polonica
1 publication, 2.78%
|
|
|
Hospital Pharmacy
1 publication, 2.78%
|
|
|
American Journal of Emergency Medicine
1 publication, 2.78%
|
|
|
Microorganisms
1 publication, 2.78%
|
|
|
European Urology Open Science
1 publication, 2.78%
|
|
|
Frontiers in Microbiology
1 publication, 2.78%
|
|
|
Urogenital Tract Infection
1 publication, 2.78%
|
|
|
The Lancet Infectious Diseases
1 publication, 2.78%
|
|
|
International Journal of Pharmaceutics
1 publication, 2.78%
|
|
|
Clinics and Practice
1 publication, 2.78%
|
|
|
Frontiers in Endocrinology
1 publication, 2.78%
|
|
|
Uro-News
1 publication, 2.78%
|
|
|
Current Opinion in Infectious Diseases
1 publication, 2.78%
|
|
|
Brazilian Journal of Infectious Diseases
1 publication, 2.78%
|
|
|
Kidney and Dialysis
1 publication, 2.78%
|
|
|
Medicine (United States)
1 publication, 2.78%
|
|
|
JAMA - Journal of the American Medical Association
1 publication, 2.78%
|
|
|
JAMA Internal Medicine
1 publication, 2.78%
|
|
|
Molecular Biology Reports
1 publication, 2.78%
|
|
|
Clinical Microbiology Reviews
1 publication, 2.78%
|
|
|
Emergency Medicine News
1 publication, 2.78%
|
|
|
EMA - Emergency Medicine Australasia
1 publication, 2.78%
|
|
|
Internal Medicine
1 publication, 2.78%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
Elsevier
7 publications, 19.44%
|
|
|
MDPI
5 publications, 13.89%
|
|
|
American Medical Association (AMA)
3 publications, 8.33%
|
|
|
Frontiers Media S.A.
3 publications, 8.33%
|
|
|
Springer Nature
3 publications, 8.33%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 8.33%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 5.56%
|
|
|
Oxford University Press
2 publications, 5.56%
|
|
|
SAGE
1 publication, 2.78%
|
|
|
Korean Association of Urogenital Tract Infection and Inflammation
1 publication, 2.78%
|
|
|
American Society for Microbiology
1 publication, 2.78%
|
|
|
Wiley
1 publication, 2.78%
|
|
|
Japanese Society of Internal Medicine
1 publication, 2.78%
|
|
|
Taylor & Francis
1 publication, 2.78%
|
|
|
Cambridge University Press
1 publication, 2.78%
|
|
|
Russian Vrach, Publishing House Ltd.
1 publication, 2.78%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.